Recent

% | $
Quotes you view appear here for quick access.

công ty Arch Therapeutics Message Board

  • bobbifleiss bobbifleiss Sep 23, 2013 10:22 AM Flag

    Acquisition Written All Over ARTH

    They are an up-and-coming company in a bandage/wound healing space that has little innovation. If their product works, this is a $500 million buyout or partnership with Johnson & Johnson.

    AC5 will not only be used in surgery, but also with primary care physicians, in households, first aid, etc. This is a great opportunity.

    Sentiment: Strong Buy

 
ARTH
0.2601+0.0321(+14.08%)Jun 30 3:59 PMEDT